{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T05:03:11Z","timestamp":1789102991269,"version":"build-2803163510"},"reference-count":49,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["23he0122018j0003"],"award-info":[{"award-number":["23he0122018j0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:sec><jats:title>Aim<\/jats:title><jats:p>Digital therapeutics (DTx) is an emerging treatment modality for enhancing psychosocial interventions <jats:italic>via<\/jats:italic> software programs, such as smartphone applications (apps). We developed a DTx named ALM\u2010003 to support treatment for people with alcohol dependence who are pursuing reduced drinking goals. ALM\u2010003 was designed to promote behavioral change through daily self\u2010monitoring with personalized feedback, interactive psychoeducational modules, and automated treatment support tools for both patients and physicians. In this multicenter, open\u2010label, randomized controlled trial (RCT), we aimed to evaluate the efficacy and safety of ALM\u2010003 in various clinical settings.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this RCT, participants with alcohol dependence without serious physical, mental, or social problems due to excessive drinking, and exhibiting high or very high drinking risk levels were randomized into an intervention group (psychosocial intervention enhanced by ALM\u2010003) or a control group (psychosocial intervention with a basic drinking diary app) for 24\u2009weeks. The primary outcome was the change in the number of heavy drinking days (HDDs) over 28\u2009days (Week 0 to Week 12).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Data analysis of the primary outcome for 136 intervention and 142 control participants was performed. Baseline HDDs were 23.2 and 23.1\u2009days\/28\u2009days in the intervention and control groups, respectively. [Correction added on 3 September 2025, after first online publication: The values of the baseline HDDs in the preceding sentence have been corrected from \u201819.4 and 19.1 days\u2019 to \u201823.2 and 23.1 days\u2019.] At Week 12, the intervention and control groups showed a reduction in HDDs of \u221212.2 and\u2009\u22129.5\u2009days from baseline, with a between\u2010group difference of \u22122.79\u2009days\/28\u2009days (95% confidence interval: \u22124.67 to \u22120.90; <jats:italic>P<\/jats:italic>\u2009=\u20090.004). Adverse events occurred in 32.9% of participants in the intervention group and 33.6% in the control group. No adverse events were attributed to app use.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>ALM\u2010003 demonstrated efficacy in reducing heavy drinking days among people with alcohol dependence at a high or very high drinking risk.<\/jats:p><\/jats:sec><jats:sec><jats:title>Clinical trial registration<\/jats:title><jats:p>The trial design was prospectively registered with the Japan Registry of Clinical Trials (jRCT) (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/jrct.niph.go.jp\/\">https:\/\/jrct.niph.go.jp\/<\/jats:ext-link>). The trial identifier is jRCT2032220560.<\/jats:p><\/jats:sec>","DOI":"10.1111\/pcn.13874","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T13:09:00Z","timestamp":1753708140000},"page":"667-676","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy and safety of a digital therapeutic for alcohol dependence: A multicenter, open\u2010label, randomized controlled trial"],"prefix":"10.1111","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9838-350X","authenticated-orcid":false,"given":"Ryuhei","family":"So","sequence":"first","affiliation":[{"name":"CureApp, Inc.  Tokyo Japan"},{"name":"Okayama Psychiatric Medical Center  Okayama Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2018-0008","authenticated-orcid":false,"given":"Kazuhiro","family":"Nouso","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology Okayama City Hospital  Okayama Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2439-7984","authenticated-orcid":false,"given":"Sachio","family":"Matsushita","sequence":"additional","affiliation":[{"name":"National Hospital Organization Kurihama Medical and Addiction Center  Yokosuka Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5243-8544","authenticated-orcid":false,"given":"Hitoshi","family":"Yoshiji","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology Nara Medical University  Nara Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8994-4010","authenticated-orcid":false,"given":"Takefumi","family":"Yuzuriha","sequence":"additional","affiliation":[{"name":"National Hospital Organization Hizen Psychiatric Medical Center  Saga Japan"},{"name":"Chikugo Yoshii Cocoro Hospital  Fukuoka Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9381-2013","authenticated-orcid":false,"given":"Eisuke","family":"Hida","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Data Science The University of Osaka Graduate School of Medicine  Osaka Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3547-1782","authenticated-orcid":false,"given":"Hiroki","family":"Nishimura","sequence":"additional","affiliation":[{"name":"CureApp, Inc.  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0305-1597","authenticated-orcid":false,"given":"Yusuke","family":"Takagi","sequence":"additional","affiliation":[{"name":"CureApp, Inc.  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9633-6785","authenticated-orcid":false,"given":"Yoshinori","family":"Horie","sequence":"additional","affiliation":[{"name":"Keiai Clinic  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,7,28]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.15357"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/agu025"},{"key":"e_1_2_9_4_1","first-page":"177","article-title":"Delay and failure in treatment seeking after first onset of mental disorders in the World Health Organization's world mental health survey initiative","volume":"6","author":"Wang PS","year":"2007","journal-title":"World Psychiatry"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2014.11.029"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1080\/00952990.2021.1969658"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881113495320"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/agu036"},{"key":"e_1_2_9_9_1","volume-title":"New Guidelines for the Diagnosis and Treatment of Alcohol and Substance Use Disorders","author":"The Japanese Society of Alcohol\u2010Related Problems","year":"2018"},{"key":"e_1_2_9_10_1","volume-title":"Alcohol Consumption Reduction Treatment Manual: Pocket Edition [Internet]","author":"Japanese Medical Society of Alcohol and Addiction Studies","year":"2019"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12875-015-0308-8"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2024.04.002"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1590\/s0004-2803.201700000-40"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1990.03450190043026"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13722-019-0140-x"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/pubmed\/fdq095"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-015-3184-y"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1465-3362.2010.00217.x"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.16157"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2024.07.003"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1989.tb00737.x"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2018.03.007"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1497.2001.016009606.x"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.73.2.262"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13722-021-00262-6"},{"key":"e_1_2_9_26_1","article-title":"Personalised digital interventions for reducing hazardous and harmful alcohol consumption in community\u2010dwelling populations","volume":"9","author":"Kaner EF","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"e_1_2_9_27_1","unstructured":"EMA.Development of medicinal products for the treatment of alcohol dependence. European Medicines Agency. 2010; [Cited 2022 Feb 8] Available fromhttps:\/\/www.ema.europa.eu\/en\/development-medicinal-products-treatment-alcohol-dependence."},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/pcn.12914"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1993.tb02093.x"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.alcohol.2010.08.012"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-014-0865-7"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-019-02310-w"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4612-0357-5_3"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1037\/0022-3514.85.2.348"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.4092\/jsre.20.56"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1080\/0963823031000103489"},{"key":"e_1_2_9_37_1","unstructured":"KawakuboA BryantFB MiyakawaE OguchiT.Development and Validation of the Japanese version of the Savoring Beliefs Inventory (SBI\u2010J). 2717\u20137564.2019;3:119\u2013136."},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.13974"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-24277-4"},{"key":"e_1_2_9_40_1","volume-title":"Statistical Principles for Clinical Trials","author":"International conference on harmonisation of technical requirements for registration of Pharmaceuticals for Human use","year":"1998"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.16421"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2010.01290.x"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/acer.13054"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/acer.13272"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/acer.14386"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/acer.13884"},{"key":"e_1_2_9_47_1","first-page":"177","article-title":"Results of post\u2010marketing surveillance study of Nalmefene in patients with alcohol dependence treated to reduce alcohol consumption: Post\u2010marketing surveillance study of Nalmefene administered for one year in daily clinical practice","volume":"62","author":"Higuchi S","year":"2025","journal-title":"Shinryo To Shinyaku (Med. Cons. New\u2010Remed.)."},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l6802"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-publhealth-032315-021402"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.00429"}],"container-title":["Psychiatry and Clinical Neurosciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/pcn.13874","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T08:11:14Z","timestamp":1759738274000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/pcn.13874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":49,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10.1111\/pcn.13874"],"URL":"https:\/\/doi.org\/10.1111\/pcn.13874","archive":["Portico"],"relation":{},"ISSN":["1323-1316","1440-1819"],"issn-type":[{"value":"1323-1316","type":"print"},{"value":"1440-1819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,28]]},"assertion":[{"value":"2024-11-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}